A statement released earlier today by Citigroup Corp. about Evonik Industries (ETR:EVK) bumps the target price to 38.00EUR
- Updated: September 17, 2016
Just yesterday Evonik Industries (ETR:EVK) traded 4.60% lower at 29.09EUR. EVK’s 50-day moving average is 2.57EUR and its 200-day average is 2.03EUR. With the last stock price close up 12.34% from the two hundred day average, compared with the Standard & Poor’s 500 Index which has decreased -0.01% over the same time. 12,913 shares of EVK traded, up from ann avg. volume of 6,409.
Indicating a possible upside of 0.31%, Citigroup Corp. upped the target stock price of Evonik Industries (ETR:EVK) to 38EUR
On 9/17/2016, Citigroup Corp. reported on Evonik Industries(ETR:EVK) upped the target price from 0.00EUR to 38.00EUR that indicated a possible upside of 0.31%.
See Graph Below:
Evonik Industries has a one-year low of 1.35EUR and a one-year high of 3.67EUR with a P/E ratio of 3. The company’s market cap is currently 0.0 EUR.
General Company Details For Evonik Industries (ETR:EVK)
Evonik Industries AG (Evonik) is a Germany-based company engaged in the specialty chemicals sector. The Company’s activities are divided in four segments: Nutrition & Care, produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as in animal nutrition and healthcare products; Resource Efficiency, offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; Performance Materials, produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and Services, includes site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at Company’s sites, and among others. It is a subsidiary of RAG Stiftung.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.